Skip to main content
. 1998 Oct 17;317(7165):1054–1059. doi: 10.1136/bmj.317.7165.1054

Table 2.

Age distribution of study population and patients in trial

Age group (years)* No (%) of registered patients in study population (n=97 229) Total No (%) of calls during the trial (n=14 492) No (%) of calls in intervention group (n=7184) No (%) of calls in control group (n=7308)
<1   476 (1) 1205 (8)  623 (9)  582 (8)
-4 5 162 (5) 2361 (16) 1137 (16)  1224 (17)
-14 12 020 (12) 1693 (12) 877 (12)  816 (11)
-24 10 557 (11) 1399 (10) 707 (10) 692 (9)
-34 14 293 (15) 1744 (12) 840 (12)  904 (12)
-44 13 676 (14) 1225 (8)  604 (9)  621 (9)
-54 13 144 (13) 1035 (7)  520 (7)  515 (7)
-64 10 004 (10) 731 (5) 362 (5)  369 (5)
-74 8 903 (9) 1000 (7)  489 (7)  511 (7)
⩾75 8 614 (9) 1825 (13) 892 (13)  933 (13)
Unknown    380 (0.4) 274 (2)  133 (0.5) 141 (2)
*

On date of call. Calculated at midpoint of trial year (22 July 1997).